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SUMMARY
Purpose: To determine whether previously unde-
tected symptoms of depression and psychiatric
help-seeking behaviors are associated with demo-
graphic or epilepsy-related variables in a predomi-
nantly African American sample of pediatric
epilepsy patients.
Methods: Ninety-six serially recruited parent–
child dyads (55% African American, 39% Cauca-
sian) completed the Short Mood and Feelings
Questionnaire (SMFQ). Regression analyses
determined whether depressive symptoms mea-
sured by the SMFQ were associated with demo-
graphic (age, gender, and ethnic background) or
epilepsy-related variables (age of seizure onset,
duration of epilepsy, seizure type, time since last
seizure, and number of antiepileptic drugs). Dyads
with positive SMFQ screens (score ‡12) received
information about depression and were advised to
seek mental health services. Six months later, par-
ents completed follow-up interviews to ascertain
mental health service utilization.
Results: Thirty-five participants (36.5%) screened
positive for probable depression. Greater number
of antiepileptic drugs was the only predictor vari-
able independently associated with greater
(worse) depression scores (p = 0.005). At 6-month
follow-up, 12 patients (36.4%) had received mental
health care, whereas 21 guardians (63.6%) denied
depressive symptoms in their child and never
sought mental health services (two dyads lost to
follow-up). Logistic regression analyses found no
associations between demographic, epilepsy-
related, or depressive variables and psychiatric
help-seeking.
Discussion: This study indicates the necessity and
feasibility of screening for previously undetected
symptoms of depression in pediatric epilepsy clin-
ics serving diverse populations, particularly among
patients receiving antiepileptic polytherapy. Addi-
tional research on the correlates of depressive
symptoms and determinants of psychiatric help-
seeking is needed to develop evidence-based inter-
ventions for youths with epilepsy and symptoms of
depression.
KEY WORDS: Pediatric epilepsy, Antiepileptic
medications, Mental health, Treatment linkage,
Evidence-based practice.
Many children and adolescents with epilepsy experi-
ence comorbid emotional and behavioral disorders
(Austin et al., 2002; Davies et al., 2003; Baker et al.,
2005). Among these, depression represents an especially
prominent concern. Epidemiologic studies (Rutter et al.,
1970; Hedderick & Buchhalter, 2003; Hesdorffer et al.,
2006) and clinic-based surveys (Ettinger et al., 1998;
Dunn et al., 1999; Baki et al., 2004; Thome-Souza
et al., 2004; Adewuya & Ola, 2005; Jones et al., 2007;
Thome-Souza et al., 2007; Turky et al., 2008) have
shown that 16–38% of youths with epilepsy screen posi-
tive for depression. These rates of depression are higher
than those found among healthy children and adoles-
cents (2–17%) (Garrison et al., 1992; Lewinsohn et al.,
1993; Hankin et al., 1998; Costello et al., 2006; The
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NSDUH Report, 2008) and children with other chronic
conditions (2–18%) (Dunitz et al., 1991; Goodwin et al.,
2005). The combined burden of depression and pediatric
epilepsy is associated with difficult family relationships
(Dunn et al., 1999; Alwash et al., 2000), social anxiety
(Baker et al., 2005), and suicidal ideation or intent
(Brent, 1986; Ettinger et al., 1998; Caplan et al., 2005;
Hesdorffer et al., 2006). Such negative outcomes high-
light the need for evidence-based standards of care that
promote the identification and treatment of depression
among children and adolescents with epilepsy (Epilepsy
Foundation, 2003).
A growing body of research has addressed this issue by
investigating potential predictors of depression in pediat-
ric epilepsy. Several demographic variables have been
examined, but the role of ethnic background in depressive
symptoms among children with epilepsy remains under-
researched. With a few notable exceptions (Ott et al.,
2001; Caplan et al., 2005; Wagner & Smith, 2007), studies
of depression in pediatric epilepsy from the United States
and Europe enrolled either largely Caucasian subjects or
did not report subject ethnicity (Ettinger et al., 1998; Dunn
et al., 1999; Hesdorffer et al., 2006; Jones et al., 2007;
Turky et al., 2008). Studies from Jordan, Turkey, Brazil,
and Nigeria examined culturally homogenous groups as
well (Alwash et al., 2000; Oguz et al., 2002; Thome-Souza
et al., 2004; Adewuya & Ola, 2005). To our knowledge,
no studies of depression in children with epilepsy have
recruited a predominately African American sample.
Other demographic variables have received more atten-
tion, but results are mixed among children with both epi-
lepsy and depression. Depression is found in pediatric
epilepsy across a wide age range, and many studies have
shown no correlation between age and depression
(Ettinger et al., 1998; Dunn et al., 1999; Baki et al., 2004;
Adewuya & Ola, 2005; Jones et al., 2007; Turky et al.,
2008). Thome-Souza et al. (2004) found psychiatric
disorders in children with epilepsy between the ages of 4
and 18 years, with depressive disorders more common
among adolescents. Similarly, when studying children
with epilepsy and depression or anxiety, Caplan et al.
(2005) found that those with depression tended to be older
than those with anxiety. The role of gender is similarly
unclear. Some studies have found no association between
gender and depression in pediatric epilepsy (Ettinger
et al., 1998; Dunn et al., 1999; Baki et al., 2004;
Thome-Souza et al., 2004; Adewuya & Ola, 2005; Jones
et al., 2007), whereas others have found that female gen-
der can be predictive of depression (Turky et al., 2008).
Considerable research has focused on the link between
epilepsy-related variables and depression in children and
adolescents with epilepsy. When comparing children with
focal epilepsy to those with generalized epilepsy, Thome-
Souza et al. (2004) found focal epilepsy to be a predictor
of psychiatric disorder. When comparing affective and
anxiety disorders among children with epilepsy, Caplan
et al. (2005) found a higher rate of anxiety disorders
among subjects with childhood absence epilepsy, whereas
subjects with complex partial seizures had a higher rate of
depression or comorbid anxiety and depression. Others
found no relationship between psychopathology and sei-
zure type among children with epilepsy (Ettinger et al.,
1998; Ott et al., 2001; Baki et al., 2004; Adewuya & Ola,
2005; Hesdorffer et al., 2006; Jones et al., 2007). Some
studies have found that depression is more common
among children with uncontrolled seizures (Oguz et al.,
2002; Adewuya & Ola, 2005), whereas others have not
(Ettinger et al., 1998; Dunn et al., 1999; Alwash et al.,
2000; Baki et al., 2004; Jones et al., 2007; Turky et al.,
2008). The link between numbers of antiepileptic drugs
(AEDs) prescribed and symptoms of depression in chil-
dren with epilepsy has also been studied. Some found that
children on AED polytherapy were at greater risk for
depression than those who were on monotherapy or not
taking medication (Oguz et al., 2002; Adewuya & Ola,
2005), whereas others found no such relationship (Ettinger
et al., 1998; Thome-Souza et al., 2004; Jones et al., 2007;
Turky et al., 2008). Additional research is needed to clar-
ify the interaction between seizure variables and depres-
sion in children with epilepsy.
Although depression is a comorbid condition com-
monly found in youth with epilepsy, mental health care
utilization in this population is low. Less than 35% of chil-
dren with both epilepsy and mental illness receive mental
health care (Ettinger et al., 1998; Ott et al., 2001; Caplan
et al., 2005). Thome-Souza et al. (2004) found a 4.35-year
lapse between depression symptom onset and diagnosis in
children and adolescents with epilepsy. Wagner and Smith
(2007) offered on-site psychological services for children
with epilepsy referred for emotional or behavioral prob-
lems; of those referred, only one-third accessed services.
Studies from the general population suggest that mental
health care utilization is especially low among children of
minority groups (Wu et al., 2001; Zimmerman, 2005;
Burgess et al., 2008). Previous authors have suggested that
lack of parental knowledge, minimization of symptoms,
and inadequate resources widen the gap between mental
health care and youth with epilepsy (Ott et al., 2003; Smith
et al., 2007; Wagner & Smith, 2007), but these barriers
have not yet been thoroughly studied in this population.
Additional research is needed to guide interventions
designed to promote effective mental health referral and
establish treatment linkage for youth with epilepsy and
depression.
Accordingly, the goals of the present study were two-
fold. First, we sought to assess the relationships between
demographic factors, epilepsy variables, and the severity
of depressive symptoms in an ethnically diverse popula-
tion of children and adolescents with epilepsy, with a sub-
stantial proportion of African American participants.
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Second, we examined the relationship between these same
factors and subsequent help-seeking behaviors among
patients with significant depressive symptomatology.
Methods
Subjects
Eligible patients and their parents/guardians were
recruited serially from an outpatient neurology clinic at
Children’s Hospital of Michigan in Detroit. Inclusion cri-
teria were: (1) patient age from 6–17 years, (2) clinical
diagnosis of epilepsy based on International League
Against Epilepsy (ILAE) criteria (Commission, 1993), (3)
presence of patient’s parent or legal guardian, and (4)
informed consent/assent from both patient and parent.
Patients were considered ineligible and excluded from the
present study if they had received mental health services
for depression during the previous 5 years, or if the clini-
cian or parent stated the child was unable to answer
screening questions. All procedures were approved by the
institutional review board at Wayne State University.
Of the 113 patients invited to take part in the study,
three families chose not to participate. Eleven dyads were
excluded because the child had already received mental
health services for depression. Three patients with a pre-
sumptive diagnosis of epilepsy were later determined to
have nonepileptic spells and were excluded from analysis.
Therefore, 96 parent–child dyads satisfied the criteria and
participated in the study. The age of child participants ran-
ged from 6–17 years (mean: 11.3 years; SD: 3.5 years);
56% of the child participants were female, 55% were
African American, 39% were Caucasian, and the remain-
ing 6% were Latino, Arab American, or Asian American
(see Table 1).








Total n = 96 n = 35 (36.5%) n = 61 (63.5%)
Age (years) 11.3 (SD = 3.5) 11.6 (SD = 3.3) 11.1 (SD = 3.6)
6–7 17 (17.7%) 4 (11.4%) 13 (21.3%)
8–9 19 (19.8%) 7 (20.0%) 12 (19.7%)
10–11 17 (17.7%) 8 (22.9%) 9 (14.8%)
12–13 13 (13.5%) 5 (14.3%) 8 (13.1%)
14–15 17 (17.7%) 7 (20.0%) 10 (16.4%)
16–17 13 (13.5%) 4 (11.4%) 9 (14.8%)
Gender
Female 54 (56.3%) 19 (54.3%) 35 (57.4%)
Male 42 (43.8%) 16 (45.7%) 26 (42.6%)
Race
African American 53 (55.2%) 18 (51.4%) 35 (57.4%)
Caucasian 37 (38.5%) 14 (40.0%) 23 (37.7%)
Other 6 (6.3%) 3 (8.6%) 3 (4.9%)
Age at onset (years) 6.9 (SD = 4.3) 6.9 (SD = 4.2) 6.9 (SD = 4.4)
0–5 42 (43.8%) 15 (42.9%) 27 (44.3%)
6–11 35 (36.5%) 14 (40.0%) 21 (34.4%)
12–17 19 (19.8%) 6 (17.1%) 13 (21.3%)
Epilepsy duration (months) 51.5 (SD = 41.5) 55.9 (SD = 41.1) 48.9 (SD = 41.8)
£12 20 (20.8%) 4 (11.4%) 16 (26.2%)
13–60 48 (50.0%) 21 (60.0%) 27 (44.3%)
>60 28 (29.2%) 10 (28.6%) 18 (29.5%)
Number of AEDs
0 12 (12.5%) 3 (8.6%) 9 (14.8%)
1 63 (65.6%) 19 (54.3%) 44 (72.1%)
2 18 (18.8%) 10 (28.6%) 8 (13.1%)
3 3 (3.1%) 3 (8.6%) 0
Last seizure (months) 8.5 (SD = 14.2) 6.5 (SD = 10.5) 9.7 (SD = 15.8)
£1 week 26 (27.1%) 12 (34.3%) 14 (23.0%)
8 days–4 months 29 (30.2%) 11 (31.4%) 18 (29.5%)
>4 months 41 (42.7%) 12 (34.3%) 29 (47.5%)
Seizure type
Generalized 31 (32.3%) 8 (22.9%) 23 (37.7%)
Focal 65 (67.7%) 27 (77.1%) 38 (62.3%)
AEDs, antiepileptic drugs.
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Measurement of depressive symptoms
Symptoms of depression were measured with the Short
Mood and Feelings Questionnaire (SMFQ), a self-report
instrument designed to screen for depression in children
and adolescents (aged 6–17 years) seen in nonpsychiatric
clinic settings (Angold et al., 1995). Using the 13-item
SMFQ-C, children rated the extent to which they had
experienced depressive symptoms in the previous
2 weeks, whereas parents separately reported the child’s
recent symptoms in a parallel version (SMFQ-P). Studies
have shown that the SMFQ is a unidimensional measure
that serves as an adequate screening tool for depression
among young children (Sharp et al., 2006) and adolescents
(Katon et al., 2008). In the original development study,
SMFQ scores were compared to those found with the Chil-
dren’s Depression Inventory (CDI) and the Diagnostic
Interview Schedule for Children (DISC) in a group of 173
children and adolescents (ages 6–17) with chronic illness.
Both the child and parent components demonstrated high
internal reliability, with alpha = 0.85 for the SMFQ-C and
alpha = 0.87 for the SMFQ-P. Using DISC depression
diagnoses as a criterion, an SMFQ-T (combined parent
and child scores) cutoff of 12 demonstrated a sensitivity of
70%, specificity of 85%, positive predictive value of 80%,
and negative predictive value of 68% for depression, and
it performed as well as the CDI in discriminating between
children with and children without a DISC diagnosis of
depression (Angold et al., 1995). Other studies have sup-
ported the validity and utility of the SMFQ in screening
for depression among similar populations (Kent et al.,
1997; Sharp et al., 2006).
In the current study, as in the original SMFQ validation
study, a member of the research team orally administered
the questionnaire in a private room to children who
requested assistance. Thirty-one children (32%) com-
pleted the questionnaire with assistance (verbally).
Twenty-three (74%) of these children were between the
ages of 6 and 8, and eight (26%) were between the ages of
9 and 13. The remainder of the study subjects answered
the questionnaire independently (written form).
All participants were assured that their responses would
remain confidential. Parent–child dyads with a combined
score below 12 were told that their scores were not indica-
tive of clinical depression. Symptoms of childhood
depression were reviewed and parents received a packet
of additional information about depression in children and
adolescents. With an SMFQ-T score of 12 or above, chil-
dren were considered to screen positive for depression,
and their parents were advised that the child or adolescent
was experiencing symptoms commonly found in pediatric
depression. After a detailed discussion of depression and
treatment, families were urged to seek mental health ser-
vices for further evaluation. These families received infor-
mational handouts from the American Academy of Child
Psychiatry, a list of available print and Internet resources,
and an invitation to attend an all-day seminar on depres-
sion in children with epilepsy sponsored by the Michigan
Epilepsy Foundation. They also received a list of local
outpatient psychiatric and psychology resources with con-
tact information.
Measurement of epilepsy variables
Subsequent to participant enrollment, epilepsy vari-
ables were obtained via chart review by the research nurse
specialist. Information recorded included the participant’s
age at seizure onset, length of time since seizure diagnosis
(duration), seizure type (as documented by a certified
pediatric neurologist), time since most recent seizure, and
current antiepileptic medications.
Measurement of help-seeking behaviors
As part of the initial consent process, all participants
were informed that dyads screening positive for symptoms
of depression would receive a 6-month follow-up phone
call to discuss mental health service utilization. At the
beginning of the follow-up interview, parents were asked
‘‘Did you obtain any mental health services for your
child?’’ Those who replied ‘‘yes’’ were asked to ‘‘describe
the type of services your child received.’’ They were also
asked if their child had been given a mental health diagno-
sis, the type of diagnosis, and who made the diagnosis.
Those who replied ‘‘no’’ were asked to ‘‘give the main rea-
son your child did not receive mental health services.’’ In
accordance with the exploratory nature of this study, fol-
low-up questions were open-ended in order to allow par-
ticipants to freely describe their experiences.
Statistical analysis
Prediction of the severity of depressive symptoms
Univariate and multiple linear regression models were
used to determine whether the severity of depressive
symptoms was associated with patient demographic pro-
files and epilepsy variables. In these regression models,
the SMFQ-T score was considered the outcome measure
and was treated as a continuous variable. Predictors
included: age in years at time of interview, gender, race
(African American, Caucasian, or other), age in years at
seizure onset, duration in months of epilepsy, time in
months since last seizure, diagnosis of generalized or focal
seizures according to seizure semiology and EEG find-
ings, and number of current antiepileptic medications
(range: 0–3).
Prediction of subsequent help-seeking behaviors
Using a univariate logistic regression analysis, we
explored whether SMFQ scores (total, parent, child),
demographic profiles, and epilepsy variables were associ-
ated with subsequent utilization of mental health services
among the participants with positive SMFQ screens.
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A multivariate logistic regression analysis was not tenable
due to the limited sample size. Utilization of mental health
services was considered the outcome measure, and predic-
tors included demographic variables, epilepsy variables,
SMFQ-T score, SMFQ-C subscore, and SMFQ-P sub-
score (Table 2). At this point, combined parent and child
SMFQ scores (SMFQ-T) were considered, as well as sepa-
rate parent scores (SMFQ-P) and child scores (SMFQ-C),
in order to examine whether parent rating of the child’s
depressive symptoms was related to subsequent help-
seeking behaviors.
All statistical analyses were performed using the com-
puter software SPSS 11.5 (SPSS Inc., Chicago, IL,
U.S.A.).
Results
Description of epilepsy variables
The mean age of seizure onset was 6.9 years [standard
deviation (SD): 4.3 years; range: infancy to 17 years].
The mean duration of epilepsy was 51.5 months (SD:
41.5 months; range: 1 month to 17 years). Seizure control
varied, with a mean of 8.5 months since last seizure (SD:
14.2 months; range: 1 day to 7 years). Thirty-two percent
of the subjects were diagnosed with generalized epilepsy,
68% had focal epilepsy, 22% were on antiepileptic poly-
therapy, 65% were on monotherapy, and 13% were not
taking antiepileptic medications (see Table 1).
Proportion of youth with epilepsy and positive SMFQ
screens
Thirty-five (36%) of participating parent–child dyads
had a score of 12 or greater on the SMFQ-T and were con-
sidered to screen positive for symptoms of depression in
the child. In reference to SMFQ-T scores, there was no
statistically significant difference between those who
answered the questionnaire orally and those who used the
written form.
Relationship between demographic profiles, epilepsy
variables, and severity of depressive symptoms
Univariate linear regression analyses revealed that
greater number of antiepileptic medications, longer dura-
tion of epilepsy, and diagnosis of focal seizures were









screens who did not seek
mental health services
Total n = 35a n = 12 (36.4%) n = 21 (63.6%)
Age (years) 11.6 (SD = 3.3) 11.6 (SD = 3.9) 11.6 (SD = 3.1)
Gender
Female 19 (54.3%) 6 (50.0%) 12 (57.1%)




18 (51.4%) 7 (58.3%) 10 (46.6%)
Caucasian 14 (40.0%) 4 (33.3%) 10 (46.6%)
Other 3 (8.6%) 1 (8.3%) 1 (4.8%)
Age at onset (years) 6.9 (SD = 4.2) 5.8 (SD = 4.9) 7.4 (SD = 3.9)
Epilepsy duration (months) 55.9 (SD = 41.1) 69.7 (SD = 48.1) 50.1 (SD = 37.3)
Number of AEDs
0 3 (8.6%) 2 (16.7%) 1 (4.8%)
1 19 (54.3%) 6 (50.0%) 12 (57.1%)
2 10 (28.6%) 2 (16.7%) 7 (33.3%)
3 3 (8.6%) 2 (16.7%) 1 (4.8%)
Last seizure (months) 6.5 (SD = 10.5) 8.2 (SD = 14.6) 6.1 (SD = 8.0)
£1 week 12 (34.3%) 5 (41.7%) 5 (23.8%)
>1 week–4 months 11 (31.4%) 3 (25.0%) 8 (38.1%)
>4 months 12 (34.3%) 4 (33.3%) 8 (38.1%)
Seizure type
Generalized 8 (22.9%) 4 (33.3%) 3 (14.3%)
Focal 27 (77.1%) 8 (66.7%) 18 (85.7%)
SMFQ-C 10.4 (SD = 5.3) 11.7 (SD = 5.6) 9.6 (SD = 5.3)
SMFQ-P 8.8 (SD = 5.5) 10.4 (SD = 6.5) 8.2 (SD = 4.9)
SMFQ-T 19.2 (SD = 7.8) 22.1 (SD = 6.4) 17.8 (SD = 8.4)
AEDs, antiepileptic drugs; SMFQ, Short Mood and Feelings Questionnaire; C, Child; P, Parent; T, Total score.
aThis column includes data from the two dyads with positive screens that were lost to follow-up.
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associated with greater SMFQ-T scores (i.e., more severe
depressive symptoms) (p < 0.05; see Table S1 on the
website). Neither the patient’s age, gender, race, age at
seizure onset, nor length of time since last seizure was
significantly associated with SMFQ-T scores.
The multiple linear regression model revealed that the
number of antiepileptic drugs was the only predictor vari-
able independently associated with a greater SMFQ-T
score (p = 0.005; regression slope = 3.91; see Table S2
on the website). A regression slope of 3.91 indicated that
each addition of an AED was associated with a 3.91 point
greater SMFQ-T score.
Of those taking a single AED, 45% were on oxcarbaze-
pine, 26% valproic acid, 11% levetiracetam, 6% ethosuxi-
mide, and 5% phenytoin. The remaining 7% were taking
carbamazepine, zonisamide, or lamotrigine. Of those tak-
ing two medications, combinations of oxcarbazepine
(50%), valproic acid (43%), lamotrigine (33%), leveti-
racetam (22%), zonisamide (17%), and topiramate (17%)
were prescribed. Carbamazepine, ethosuximide, Cloba-
zam, vigabatrin, and clorazepate were also being taken,
each by a single patient in combination with another medi-
cation. Of those taking three medications, combinations of
oxcarbazepine, valproic acid, zonisamide, phenytoin, car-
bamazepine, and lamotrigine were prescribed. Because of
sample size and number of medications given in a variety
of combinations, we were unable to analyze the relation-
ship between specific medications and SMFQ scores.
Mental health-seeking behaviors
Of the 35 parent–child dyads that screened positive for
symptoms of depression, two were lost to follow-up and
did not complete this portion of the study. Of the remain-
ing 33 families contacted by phone 6 months after screen-
ing, 12 (36%) had obtained mental health services for
their child. Univariate logistic regression analyses failed
to find a significant association between demographic fac-
tors, epilepsy variables, SMFQ-T scores, SMFQ-C and
SMFQ-P subscores, and mental health help-seeking
behaviors (see Table 2; see also Table S3 on the website).
Of the 12 children who received mental health services,
two 6-year-old boys were subsequently diagnosed with
attention deficit hyperactivity disorder (ADHD) and were
receiving ongoing treatment. Three 8–13-year-olds were
being followed by a school counselor for academic or
behavioral issues. Four others aged 7–17 years were being
followed by a psychiatrist for treatment of depression; of
these, two had been admitted to a psychiatric inpatient
facility for treatment of suicidal ideation. One additional
child was being treated for self-injury, one child was diag-
nosed with anxiety, and one family stated the child was
receiving psychiatric treatment, but preferred not to dis-
close a diagnosis.
The remaining 21 families did not obtain, nor did they
attempt to obtain, mental health services for their children.
When asked for the main reason mental health services
were not sought, all 21 parents stated, ‘‘s/he does not have
depression, s/he is just a moody teenager, s/he was just
upset that day, s/he is fine’’ or ‘‘depression is not a prob-
lem for him/her.’’ Two parents stated that they were moni-
toring their child’s mood, but did not think that a formal
evaluation or intervention was warranted. Without excep-
tion, denial of clinical depression was named as the reason
for not seeking treatment, and no other barriers to mental
health services were mentioned. In addition, no families in
this study attended the seminar on depression in pediatric
epilepsy.
Discussion
The purpose of this study was to identify factors related
to previously undetected symptoms of depression and
mental health help-seeking behaviors in an ethnically
diverse population of children and adolescents with epi-
lepsy. With the exception of the number of AEDs, no epi-
lepsy-related or demographic variables examined were
independent predictors of previously undetected symp-
toms of depression. Neither demographic nor epilepsy-
related variables predicted mental health help-seeking
behaviors in this predominately African American sample.
Demographics
Using SMFQ-T scores, 36% of the children and adoles-
cents who entered our study screened positive for previ-
ously undetected symptoms of depression. Similar results
have been reported in other studies surveying children and
adolescents with epilepsy (Ettinger et al., 1998; Dunn
et al., 1999; Alwash et al., 2000; Oguz et al., 2002;
Thome-Souza et al., 2004; Adewuya & Ola, 2005; Caplan
et al., 2005; Jones et al., 2007; Turky et al., 2008). Consis-
tent with previous studies (Ettinger et al., 1998; Baki
et al., 2004; Adewuya & Ola, 2005; Jones et al., 2007), no
significant association was found between age or gender
and symptoms of depression. The present study is unique
in that it was characterized by a predominantly African
American and racially diverse sample. Our data indicate
that African American and Caucasian patients attending
tertiary pediatric epilepsy clinics experience previously
undetected symptoms of depression at similarly high rates,
and screening for depression among this population is
equally important across age, gender, and ethnic back-
ground.
Epilepsy-related variables
Consistent with previous findings (Ettinger et al., 1998;
Dunn et al., 1999; Ott et al., 2001; Baki et al., 2004; Jones
et al., 2007), the present data demonstrated no association
between age of seizure onset, duration of epilepsy, seizure
type, time since last seizure, and symptoms of depression.
Greater number of AEDs was the only variable indepen-
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dently predictive of more severe symptoms of depression.
This correlation persisted even after controlling for age at
seizure onset, duration of epilepsy, seizure type, and time
since last seizure. This finding corresponds to studies
examining medication subgroups sufficiently large for
meaningful analysis (Oguz et al., 2002; Adewuya & Ola,
2005) and adds to the growing body of evidence, suggest-
ing that the number of AEDs prescribed is an important
independent risk factor for previously undetected symp-
toms of depression in pediatric epilepsy. Although further
research in this area is necessary, these collective findings
indicate that youths receiving AED polytherapy may be
an important subgroup for regular depression screening
and intervention. With changes in medication, outcomes
should be evaluated both in terms of seizure control and
mood.
It is difficult to define the relationship between antiepi-
leptic drugs and symptoms of depression in children and
adolescents with epilepsy. Valproic acid may stabilize
mood in children at risk for bipolar disorder (Pavuluri
et al., 2005; Saxena et al., 2006), and phenytoin, (Mishory
et al., 2003, carbamazepine, lamotrigine (Mokhber et al.,
2008), and zonisamide (Ghaemi, et al., 2006) have demon-
strated mood-stabilizing effects on adults with psychopa-
thology. On the other hand, levetiracetam and vigabatrin
can exacerbate behavioral problems in vulnerable
individuals (Levinson & Devinsky, 1999; Ben-Menachem
& Gilland, 2003), and cognitive changes have been
described in individuals taking topiramate (Gomer et al.,
2007; Bootsma et al., 2008). In addition, AED side effects
can mimic symptoms of depression such as psychomotor
retardation, sleep disturbance, change in appetite, and
difficulty with concentration (see Besag, 2001; Glauser,
2004; Mula & Sander, 2007 for reviews).When given in
combination, it is particularly difficult to interpret the
relative influence these medications have on symptoms of
depression. Future research is needed to disentangle this
complex problem as it relates to children with epilepsy
and symptoms of depression.
Help-seeking behaviors
In the current study, 12 (36%) of the 33 parent–child
dyads advised to obtain mental health services did indeed
seek and obtain mental health care for their child such as
school counseling, private therapy, or psychiatric care.
The remaining 21 parents stated that their child’s symp-
toms did not warrant formal mental health intervention.
The decision to seek psychiatric care was not linked to any
demographic variables, epilepsy-related variables, parent
ratings of child depressive symptoms, or severity of
depressive symptoms at the time of screening. Specifi-
cally, there was no association between ethnic background
(African American, Caucasian, other) and mental health
seeking behaviors among these families caring for chil-
dren and adolescents with epilepsy.
Previous studies in the general population have indi-
cated that African American children and adolescents are
less likely than Caucasians to receive mental health
services (Cunningham & Freiman, 1996; Wu et al., 2001;
Sen, 2004; Zimmerman, 2005), and that female children
and adolescents are more likely than their male peers to
seek services for emotional problems (Rickwood &
Braithwaite, 1994; Sen, 2004). In the present study,
help-seeking behaviors (or lack thereof) remained consis-
tent across gender and ethnic background. African
Americans were just as likely to seek mental health care
services for their child or adolescent with epilepsy as
Caucasians, and male subjects were just as likely as
female subjects to receive mental health care services.
Such findings suggest that mental health help-seeking
behaviors among this group may differ from those found
in the general population. Perhaps established connection
with specialty providers, the added burden of a possible
second diagnosis, or fear of compounded stigma, differ-
entiate this group from the general population. Further
research specific to pediatric epilepsy is needed to iden-
tify factors influencing a family’s decision to seek mental
health services for diverse populations of children and
adolescents with epilepsy.
Although many studies have proposed depression
screening, education, and referral as a standard of care for
children with epilepsy (Dunn et al., 1999; Baki et al.,
2004; Adewuya & Ola, 2005), little is known about subse-
quent behaviors and outcomes. To our knowledge, this is
the first study of psychiatric help-seeking in pediatric epi-
lepsy subsequent to depression screening, targeted educa-
tion, and follow-up recommendations. This intervention
mobilized some families to seek mental health services
but was not sufficient for the majority of cases. Among
those who did not obtain mental health care for their child,
none expressed frustration with barriers to services.
Rather, these parents uniformly discounted screening
results and dismissed follow-up recommendations.
Douma et al. (2006) reported similar findings among
parents of children with intellectual disabilities and
psychopathology, and studies from the general population
have found that parental evaluation of a child’s behavior
and perception of mental health care services were corre-
lated with subsequent treatment utilization (McMiller &
Weisz, 1996; Flisher et al., 1997; Zahner & Daskalakis,
1997; Pescosolido et al., 2008). Poor access and inade-
quate coverage may block access to mental health services
for some children with epilepsy, but in this study, it
appears that parental reluctance to acknowledge the need
for intervention trumped these barriers. This finding per-
sisted for both African American and Caucasian subjects.
Perhaps interventions such as: discussion of depression as
a comorbid risk factor at the time epilepsy is diagnosed;
exploration of the rationale used by parents to discount
screening results and follow-up recommendations; or
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repeated on-site screening would promote mental
health care linkage. Additional research is needed to
identify methods that promote parental understanding of
depressive symptoms and increase willingness to seek
mental health care.
Limitations
These results must be interpreted in light of the present
study’s methodologic limitations. First, symptoms of
depression were measured using a self-report screening
tool, rather than a clinical psychiatric evaluation. We did
not formally assess participants’ cognitive abilities prior
to administering the screening measure. In addition, the
screening tool was not re-administered during the follow-
up phone contact. Therefore, the proportions reported for
this study indicate probable, but not confirmed, cases of
previously undiagnosed depression.
Secondly, we recruited a convenience sample of
patients drawn from a tertiary care center. These sample
characteristics were beneficial in several respects but may
not be representative of the general pediatric epilepsy pop-
ulation, especially with respect to seizure-related variables
and number of antiepileptic medications prescribed. A
small subsample was used to evaluate variables related to
help-seeking behaviors, and generalizations based on a
sample of this size must be made with care. In addition,
this study did not attempt to assess the role of socioeco-
nomic status as it related to symptoms of depression or
psychiatric help-seeking behaviors.
Conclusion
This study supports the utility and necessity of screen-
ing for previously undetected symptoms of depression in
tertiary pediatric epilepsy clinics serving both African
American and Caucasian children. Screening for and dis-
cussion of depression symptoms were acceptable to the
vast majority of those invited to participate in the study,
with only 3% declining to enroll. The time required to
administer the SMFQ did not disrupt clinic flow and
presented an opportunity for dialogue on depression in
pediatric epilepsy. In addition, it is encouraging that this
brief intervention resulted in relevant outcomes for 12
children with previously undetected symptoms of
depression who received ongoing mental health services
subsequent to this study. However, the lack of help-
seeking among the remaining 21 families is cause for
concern. Although our study supports the assertion that
depression in pediatric epilepsy is largely underdiag-
nosed and undertreated for both African American and
Caucasian children and adolescents, it also highlights
the need for further research to illuminate determinants
of psychiatric help-seeking behaviors among parents of
youth with epilepsy.
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